
Scientists have hailed a potentially “revolutionary” breakthrough in Alzheimer’s research as a blood test was found to be accurate at detecting early signs of the disease.
The ALZpath ptau217 test works by identifying a protein called p-tau217 in the blood that is a biological marker of the disease.